CJMB Stock Forecast: Callan JMB, Inc. Price Predictions for 2026-2027
Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 4 of 100 as at 12 Sept 2026 — in the weakest quartile.
CJMB stock analysis: one number for the whole business
Consensus tells you what everyone already believes. The model scores Callan JMB, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (91): Smaller than most of the companies we track.
Issuance (1): The company has been issuing shares or taking on financing, diluting existing holders.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
CJMB stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on CJMB, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
This page is one stock. Monday covers all of them.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CJMB appears on the weeks it earns a place.
CJMB vs the S&P 500
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 14 Sept 2026, Callan JMB, Inc. returned −56.8% against +17.0% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
CJMB analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Callan JMB, Inc. (CJMB) financial data
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- −1.2×
- Price / sales
- 2.6×
- Price / book
- 19.2×
- EV / EBITDA
- −2.2×
Cheaper than 83% of US stocks
Cheaper than 46% of US stocks
Cheaper than 5% of US stocks
Cheaper than 72% of US stocks
- Revenue growth (YoY)
- −17.4%
- Earnings growth (YoY)
- −17.4%
- Gross margin
- 55.1%
- Operating margin
- −97.8%
- Net margin
- −192.0%
Higher than 12% of US stocks
Higher than 22% of US stocks
Higher than 68% of US stocks
Higher than 14% of US stocks
Higher than 3% of US stocks
- Return on equity
- −300.3%
- Return on assets
- −64.2%
- Dividend yield
- —
Higher than 5% of US stocks
Higher than 5% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
Callan JMB, Inc. (CJMB) statistics: revenue, profit & scale
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Callan JMB, Inc. has a market value of $13.2M and an enterprise value of $14.5M.
Revenue in the twelve months to 30 June 2026: $5.1M. The latest quarter shrank 17.4% year on year.
Net income over the same four quarters: −$9.8M, a −192.0% net margin.
Free cash flow in the twelve months to 30 June 2026: −$4.7M.
Trailing P/E: −1.2×.
Callan JMB, Inc. employs 18 people — $283K of revenue per employee.
Data provided by Twelve Data
CJMB vs competitors
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Callan JMB, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Frequently asked questions about CJMB stock
How does Ticker Nerd's model rank CJMB?
As at 12 Sept 2026, Callan JMB, Inc. ranks 4 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (91 of 100).
What is the CJMB stock forecast for 2030?
No analyst covering Callan JMB, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CJMB are extrapolating price history, which says nothing about the business.
How has CJMB stock performed over the past year?
Callan JMB, Inc. returned -56.8% over the 12 months to 14 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.
What does Callan JMB, Inc. do?
Callan JMB Inc. is a specialty logistics and fulfillment company focused on temperature-controlled handling for the life sciences sector.
About Callan JMB, Inc.
Callan JMB Inc. is a specialty logistics and fulfillment company focused on temperature-controlled handling for the life sciences sector. The company provides cold chain solutions that support the transport, storage, monitoring, and protection of highly sensitive medical and biological materials, including vaccines, diagnostics, cell therapies, stem cells, biopharmaceuticals, and other regulated products. Its services combine proprietary packaging, information technology, and specialized cold chain know-how to help maintain product integrity across time-sensitive supply chains. Callan JMB also serves emergency preparedness and response needs through product fulfillment, medical stockpiles, and rapid deployment support for critical materials. Based in Spring Branch, Texas, the company operates through its principal subsidiary and works with healthcare, pharmaceutical, and emergency management customers that require compliant, reliable logistics for essential products.
CEO Mr. Wayne Williams · 18 employees · United States · https://callanjmb.com